Our 2015 International Interchange will illustrate the practical, effective use of CDISC standards, while concentrating on future endeavors that promise even greater opportunities for patients globally.
Austin, TX (PRWEB) October 29, 2015
The Clinical Data Interchange Standards Consortium (CDISC) announced today that it plans to commemorate its 15-year anniversary and reveal a new, patient-centered messaging campaign at its upcoming International Interchange, to be held 10-11 November 2015 in Chicago, Illinois.
The conference theme and campaign tagline, “Smarter Research to Unlock Cures,” supports numerous healthcare-driven presentations and open panel discussions that will be held during the event with experts across the medical research and healthcare industries. Dr. Rob Califf, FDA Commissioner nominee and CDISC advocate, will offer a Keynote Address during the conference, highlighting the need to change the research paradigm.
Other notable topics to be covered at the CDISC International Interchange include progress in developing standards to support therapeutic areas such as diabetes and cancer; the need for standards to ensure the success of 21st Century Cures legislation; standards-based application of electronic health records for regulated research; global regulatory requirements for CDISC standards; metrics and case studies on the use of CDISC standards in research; experiences of the inaugural group of CDISC Fellows; and, the SHARE metadata repository that provides the standards in electronic format.
“The adoption of the CDISC standards has been steadily increasing as users, including regulators, continue to appreciate their value in streamlining data sharing and paving the way to new treatments for patients,” Dr. Rebecca Kush, CDISC President and CEO asserted. “We are effectively ‘unlocking’ a world of cures, some of which could be missed without standards that allow that data to speak the same language.”
Dr. Nicole Harmon, Executive Director of CDISC, affirmed, “Our 2015 International Interchange will illustrate the practical, effective use of CDISC standards, while concentrating on future endeavors that promise even greater opportunities for patients globally. That this year marks the 15th anniversary of CDISC’s incorporation only gilds this level of success, and we are excited to celebrate this milestone with our members and supportive community.”
Incorporated as a non-profit organization in 2000, CDISC released its first production models that year, with a steady record of accomplishment ever since. Over the past 15 years, CDISC and its numerous volunteers have worked to develop a suite of beginning-to-end, consensus-based standards that enable data sharing and reuse through the entire clinical research process, supporting the faster development of therapies for patients.
The CDISC International Interchange conference days will be held 10-11 November 2015, with a wide array of CDISC Authorized Education Course offerings available on 09, 12 and 13 November. CDISC is grateful to all those that have contributed to making the CDISC Interchanges possible, notably Accenture, for their continued global diamond sponsorship of the CDISC Interchanges, as well as a large number of sponsors and exhibitors. To learn more about the 2015 CDISC International Interchange, please visit the International Interchange page on the CDISC website.
CDISC is a 501(c)(3) global non-profit charitable organization, with over 380 member organizations supporting medical research and a learning health system. Through the efforts of volunteers around the world, CDISC works to develop industry-wide data standards to streamline research and its link with healthcare. Such standards allow researchers to speak the same language, enabling Smarter Research to Unlock Cures. CDISC standards allow information to be shared more easily, improving quality and decreasing costs, with the ultimate goal of accelerating the development of new treatments for patients. CDISC partners with the Critical Path Institute and collaborates with numerous organizations (including the National Cancer Institute’s Enterprise Vocabulary Services, the U.S. Food and Drug Administration and Japan’s Pharmaceutical and Medical Devices Agency) to develop therapeutic area standards through the Coalition For Accelerating Standards and Therapies (CFAST).